Skip to main content

Table 3 Long-term outcomes in non-frail vs frail patients

From: Relevance of presenting risks of frailty, sarcopaenia and osteopaenia to outcomes from aneurysmal subarachnoid haemorrhage

  Unadjusted Adjusted
    Overall Non-Frail
(n = 20)
Frail
(n = 31)
OR (95% CI) P Value OR (95% CI) P Value
mRS 3 months Median (1Q – 3Q) 1 (0 – 3) 1 (0 – 1) 2 (1 – 4) - 0.005 - 0.015
1 year Median (1Q – 3Q) 0 (0 – 2) 0 (0 – 1) 1 (0 – 4) - 0.038 - 0.064
Favourable mRS 3 months Frequency (%) 39 (76.5) 19 (95.0) 20 (64.5) 10.5 (1.23 – 88) 0.017 9.01 (1.02 – 79) 0.048
1 year Frequency (%) 42 (82.4) 19 (95.0) 23 (74.2) 6.61 (0.76 – 57) 0.072 5.21 (0.54 – 50) 0.15
Mortality 30 day Frequency (%) 1 (2.0) 0 (0) 1 (3.2) - 1.00 - 1.00
6 months Frequency (%) 1 (2.0) 0 (0) 1 (3.2) - 1.00 - 1.00
1 year Frequency (%) 2 (3.9) 0 (0) 2 (6.5) - 0.52 - 1.00
3 year Frequency (%) 3 (5.9) 0 (0) 3 (9.7) - 0.29 - 1.00
5 year Frequency (%) 5 (9.8) 0 (0) 5 (16.7) - 0.14 - 1.00
  1. mRS Modified Rankin scale